| Molecular Formula | C32H29NO5 |
| Molar Mass | 507.58 |
| Density | 1.256±0.06 g/cm3(Predicted) |
| Boling Point | 745.3±60.0 °C(Predicted) |
| Solubility | DMSO: ≥ 34 mg/mL |
| pKa | 3.54±0.20(Predicted) |
| Storage Condition | Sealed in dry,Store in freezer, under -20°C |
| In vivo study | EMA401 (10 mg/kg; p.o.) results in a significant attenuation of theta power and increase in paw withdrawal latencies (PWL) in rats at day 14 after chronic constriction injury (CCI). |
| 1mg | 5mg | 10mg | |
|---|---|---|---|
| 1 mM | 1.97 ml | 9.851 ml | 19.701 ml |
| 5 mM | 0.394 ml | 1.97 ml | 3.94 ml |
| 10 mM | 0.197 ml | 0.985 ml | 1.97 ml |
| 5 mM | 0.039 ml | 0.197 ml | 0.394 ml |